Houlihan Lokey HLI
- Market cap
- $9.2B
- PE
- 22.0×
- 10y median 21.4×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.6×
- EV/EBIT
- 17.2×
- Revenue, 12 months
- $2.5B
- +2% on a year ago
- Net margin
- 16.1%
- Free cash flow yield
- 5.3%
Houlihan Lokey trades at 22.0× trailing earnings, near its ten-year median. Revenue was $2.5B over the last twelve months, up 2% on a year earlier with a 16% net margin.
Charts
Financials
| Income statement | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $467M−5% | $511.1M+12% | $520.5M+17% | $513.6M+24% | $575M+23% | $634.4M+24% | $666.4M+28% | $605.3M+18% | $659.5M+15% | $717.1M+13% | $635.6M−5% | $511M−16% | |
| $90.3M+1% | $96.5M+15% | $102.7M+13% | $94.7M+29% | $130.7M+45% | $136.1M+41% | $141.1M+37% | $89.8M−5% | $151.3M+16% | $160.7M+18% | $125.1M−11% | $78M−13% | |
| Pre-tax income | $93.6M+11% | $102.6M+23% | $118M+47% | $99.9M+31% | $136.1M+45% | $145.1M+42% | $150.3M+27% | $98M−2% | $160.1M+18% | $169.6M+17% | $134.5M−11% | $86M−12% |
| $26.5M+13% | $31.8M+55% | $37M+79% | $10.9M−27% | $42.5M+60% | $49.8M+57% | $28.3M−23% | $0 | $48.3M+14% | $53.1M+7% | $36.2M+28% | $8M | |
| Net income | $67M+10% | $70.8M+12% | $81.1M+36% | $88.9M+45% | $93.5M+40% | $95.3M+35% | $121.9M+50% | $97.5M+10% | $111.8M+20% | $116.5M+22% | $99.8M−18% | $78M−20% |
| $0.99+14% | $1.04+16% | $1.18+23% | $1.30+44% | $1.37+38% | $1.39+34% | $1.77+50% | $1.42+9% | $1.63+19% | $1.70+22% | $1.48−16% | $1.15−19% | |
| 67.9M−3% | 67.9M−3% | 69M+11% | 68.5M+1% | 68.4M+1% | 68.8M+1% | 69M+0% | 68.9M+1% | 68.6M+0% | 68.4M−1% | 67.7M−2% | 67.6M−2% |
Operating income: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Income tax: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Net income: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
EPS, diluted: 11 periods, Q1 FY15 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY15: share-days: the 6-month average less the second quarter's. 12 periods, Q4 FY15 to Q4 FY26: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Asset Management nearest Houlihan Lokey's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HLIHoulihan Lokey | $9.2B | 22.0× | 21.4× | 3.6× | +2% | 16.1% | |
| EVREvercore | $9.7B | 14.2× | 18.1× | 2.0× | +46% | 15.7% | |
| AMGAffiliated Managers | $9.9B | 13.6× | 13.7× | 4.4× | +12% | 37.7% | |
| IDCCInterDigital | $8.4B | 37.7× | 23.0× | 10.7× | −12% | 38.3% | |
| MORNMorningstar | $8.4B | 21.3× | 39.7× | 3.3× | +9% | 16.4% | |
| VCTRVictory Capital | $6.6B | 19.7× | 12.0× | 4.2× | +52% | 29.6% | |
| CGCarlyle | $13.8B | 40.2× | 13.2× | 3.8× | −42% | 10.1% | |
| DLBDolby Laboratories | $5.9B | 26.7× | 31.2× | 4.3× | +1% | 16.7% | |
| OWLBlue OWL Capital | $14.6B | 78.0× | 185× | 4.9× | +14% | 2.7% | |
| BENFranklin Resources | $15.8B | 21.1× | 14.2× | 1.7× | +8% | 8.7% | |
| TPGTPG | $17.2B | 82.7× | 177× | 3.4× | +30% | 4.7% | |
| Peer median | $9.8B | 24.0× | 20.5× | 4.0× | +11% | 16.1% |
Investors who own it
Investors we follow who held Houlihan Lokey at the end of Jun 30, 2026, from their 13F filings.
- Ron BaronBaron Capital0.2% of portfoliotrimmed
More on Houlihan Lokey
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Asset Management
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .